ArticleBMC gastroenterology2025
Primary liver cancer disease burden in Cambodia during 1990-2021: a systematic analysis of datasets from the global burden of disease study 2021.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lapatinib Promotes Apoptosis in Hepatoma Cells by Regulating SPP1 Expression.Anti-cancer agents in medicinal chemistry · 2026Article
- The relationship between resilience, financial toxicity, and quality of life in patients with primary liver cancer: a cross-sectional study.BMC gastroenterology · 2025Article
- Global burden of disease among adolescents and young adults with drug use disorders, 1990-2021: based on GBD 2021.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe etiological composition and disease burden of hepatocellular carcinoma (HCC) in Cambodia show significant dynamic changes, and targeted prevention and control strategies are urgently needed.
methodsFirst, this study obtained data on HCC by age, sex, etiology, incidence, prevalence, deaths, disability-adjusted life years (DALYs), and attributable risk from the 2021 GBD study focused on Cambodia data from 1990 to 2021. Secondly, the study also examined the temporal trend of subtype-specific HCC disease burden in Cambodia from 1990 to 2021 using linear regression modeling to calculate estimated annual percentage change (EAPC) values. Finally, risk factors for HCC of different etiologies were also analyzed.
resultsAlthough the age-standardized rate (ASR) of HBV, HCV and NAFLD-related HCC showed a downward trend, the total number of cases and the number of deaths continued to increase. The ASR of HCC related to alcoholic liver disease rose against the trend. The burden of HBV and HCC related to alcoholic liver disease is significantly heavier in men, while the burden of HCC related to HCV and NAFLD is more severe in women. Viral hepatitis (HBV/HCV) remains the main cause of liver cancer in Cambodia, but the contribution of metabolic causes (NAFLD) continues to rise.
conclusionHCC poses a significant threat to the health of Cambodians. This study provides key data support for Cambodia to formulate a comprehensive prevention and control strategy for HCC that is "virus control - metabolic intervention - gender stratification".
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.